These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19888064)

  • 1. ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
    Obstet Gynecol; 2009 Oct; 114(4):950. PubMed ID: 19888064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
    ACOG Committee on Genetics
    Obstet Gynecol; 2004 Aug; 104(2):425-8. PubMed ID: 15292027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ashkenazi Jewish screening in the twenty-first century.
    Klugman S; Gross SJ
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):37-46. PubMed ID: 20494256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.
    Kalman L; Wilson JA; Buller A; Dixon J; Edelmann L; Geller L; Highsmith WE; Holtegaard L; Kornreich R; Rohlfs EM; Payeur TL; Sellers T; Toji L; Muralidharan K
    J Mol Diagn; 2009 Nov; 11(6):530-6. PubMed ID: 19815695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected genetic disorders affecting Ashkenazi Jewish families.
    Weinstein LB
    Fam Community Health; 2007; 30(1):50-62. PubMed ID: 17149032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR; Gollust SE; Hull SC; Wilfond BS
    Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier testing for autosomal-recessive disorders.
    Vallance H; Ford J
    Crit Rev Clin Lab Sci; 2003 Aug; 40(4):473-97. PubMed ID: 14582604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.
    Schrijver I; Külm M; Gardner PI; Pergament EP; Fiddler MB
    J Mol Diagn; 2007 Apr; 9(2):228-36. PubMed ID: 17384215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-examination of the use of ethnicity in prenatal carrier testing.
    Ross LF
    Am J Med Genet A; 2012 Jan; 158A(1):19-23. PubMed ID: 22106058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier screening for genetic disorders in individuals of Ashkenazi Jewish descent.
    Langlois S; Wilson RD; ;
    J Obstet Gynaecol Can; 2006 Apr; 28(4):324-332. PubMed ID: 16776912
    [No Abstract]   [Full Text] [Related]  

  • 15. Tay-Sachs disease screening and counseling families at risk for metabolic disease.
    Sutton VR
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):287-96. PubMed ID: 12108829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
    Obstet Gynecol; 2017 Mar; 129(3):e41-e55. PubMed ID: 28225426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease.
    ACOG Committee on Genetics
    Obstet Gynecol; 2005 Oct; 106(4):893-4. PubMed ID: 16199656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
    Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.